Lilly Announces Agreement To Acquire ARMO BioSciences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Baird Downgrades ARMO BioSciences, Inc. (ARMO) to Neutral Following Acquisition
May 10, 2018 12:27 PM EDTBaird downgraded ARMO BioSciences, Inc. (NASDAQ: ARMO) from Outperform to Neutral with a price target of $50.00 (from $67.00).
For an analyst ratings summary and ratings history on ARMO BioSciences, Inc. click here. For more ratings news on ARMO BioSciences, Inc. click here.
Shares of ARMO BioSciences, Inc. closed at $29.82 yesterday.
... MoreBMO Capital Downgrades ARMO BioSciences, Inc. (ARMO) to Market Perform Following Takeover
May 10, 2018 11:03 AM EDTBMO Capital downgraded ARMO BioSciences, Inc. (NASDAQ: ARMO) from Outperform to Market Perform with a price target of $50.00.
For an analyst ratings summary and ratings history on ARMO BioSciences, Inc. click here. For more ratings news on ARMO BioSciences, Inc. click here.
Shares of ARMO BioSciences, Inc. closed at $29.82 yesterday.
... More